About ZZ Biotech
ZZ Biotech is a company based in Houston (United States) founded in 2006. ZZ Biotech has completed 1 acquisition, including Bioatrix. ZZ Biotech offers products and services including 3K3A-APC. ZZ Biotech operates in a competitive market with competitors including Basking Biosciences, Acticor Biotech, Remedy Pharmaceuticals, Alveron Pharma and Aurum Biosciences, among others.
- Headquarter Houston, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zz Biotech, Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ZZ Biotech
ZZ Biotech offers a comprehensive portfolio of products and services, including 3K3A-APC.
Genetically engineered variant of human protein C for therapeutic applications.
People of ZZ Biotech
Unlock access to complete
Unlock access to complete
Leadership Team
4 people
Finance and Accounting
1 people
Legal and Compliance
1 people
Head Team
1 people
Unlock access to complete
Funding Insights of ZZ Biotech
Investors in ZZ Biotech
ZZ Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include NIH.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked |
Investor details for ZZ Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ZZ Biotech
ZZ Biotech has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Bioatrix.
Investment portfolio details for ZZ Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developing activated protein C (aPC)-based products primarily for wound healing
|
Locked | Locked | 2012 | Locked |
Complete acquisition details for ZZ Biotech
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - ZZ Biotech
Detailed financials for ZZ Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zz Biotech Comparisons
Peer comparison for ZZ Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ZZ Biotech
ZZ Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Basking Biosciences, Acticor Biotech, Remedy Pharmaceuticals, Alveron Pharma and Aurum Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for ischemic stroke treatment are developed.
|
|
| Locked | Locked | Locked |
Immunotherapeutics are developed for ischemic stroke treatment using monoclonal antibodies.
|
|
| Locked | Locked | Locked |
Intravenous formulation for acute central nervous system conditions such as stroke (ischemic and hemorrhagic), traumatic brain injury.
|
|
| Locked | Locked | Locked |
Drugs for haemorrhagic stroke and intracranial haemorrhage are developed.
|
|
| Locked | Locked | Locked |
Novel oxygen carriers and MRI software for stroke are developed.
|
Detailed competitors of ZZ Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zz Biotech
Complete news archive for ZZ Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ZZ Biotech
ZZ Biotech was founded in 2006 and raised its 1st funding round 8 years after it was founded.
ZZ Biotech is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Kent Pryor is the current CEO of ZZ Biotech.
ZZ Biotech was founded in 2006 in Houston, United States, within the biotechnology sector. Focus is placed on biological therapies for conditions affecting the aging and damaged brain, such as stroke and neurodegenerative diseases. The lead product, 3K3A-APC, represents a modified form of activated protein C and is undergoing phase 2 clinical trials. Functions related to cell protection, inflammation reduction, and blood clotting regulation are attributed to this candidate.
ZZ Biotech's top competitors include Acticor Biotech, Remedy Pharmaceuticals and Basking Biosciences.
ZZ Biotech offers 3K3A-APC.
ZZ Biotech has made 1 acquisition, including Bioatrix.
ZZ Biotech has 1 investor. Key investors include NIH.